Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Hashimoto D, Satoi S, Yamaki S, Nakayama S, Shibata N, Matsumura K, Miyazaki H, Matsui Y, Tsybulskyi D, Sang NT, Ikeura T, Kanai M, Sekimoto M. Hashimoto D, et al. Among authors: matsumura k. Ann Surg Oncol. 2025 Jan;32(1):517-528. doi: 10.1245/s10434-024-16361-y. Epub 2024 Oct 21. Ann Surg Oncol. 2025. PMID: 39433718
Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma.
Maruo M, Ikeura T, Takaori A, Ikeda M, Nakamaru K, Ito T, Masuda M, Mitsuyama T, Nakayama S, Shimatani M, Takaoka M, Shibata N, Boku S, Yasuda T, Miyazaki H, Matsumura K, Yamaki S, Hashimoto D, Satoi S, Naganuma M. Maruo M, et al. Among authors: matsumura k. Pancreatology. 2024 Aug;24(5):787-795. doi: 10.1016/j.pan.2024.06.001. Epub 2024 Jun 6. Pancreatology. 2024. PMID: 38871559
ASO Visual Abstract: Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Hashimoto D, Satoi S, Yamaki S, Nakayama S, Shibata N, Matsumura K, Miyazaki H, Matsui Y, Tsybulskyi D, Sang NT, Ikeura T, Kanai M, Sekimoto M. Hashimoto D, et al. Among authors: matsumura k. Ann Surg Oncol. 2025 Feb;32(2):1341. doi: 10.1245/s10434-024-16502-3. Ann Surg Oncol. 2025. PMID: 39542964 No abstract available.
Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma.
Hayashi H, Uemura N, Zhao L, Matsumura K, Sato H, Shiraishi Y, Baba H. Hayashi H, et al. Among authors: matsumura k. Front Oncol. 2021 Jul 29;11:700315. doi: 10.3389/fonc.2021.700315. eCollection 2021. Front Oncol. 2021. PMID: 34395269 Free PMC article. Review.
Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma.
Matsumura K, Hayashi H, Uemura N, Ogata Y, Zhao L, Sato H, Shiraishi Y, Kuroki H, Kitamura F, Kaida T, Higashi T, Nakagawa S, Mima K, Imai K, Yamashita YI, Baba H. Matsumura K, et al. Transl Oncol. 2022 Dec;26:101533. doi: 10.1016/j.tranon.2022.101533. Epub 2022 Sep 15. Transl Oncol. 2022. PMID: 36115074 Free PMC article.
1,524 results